SGS Life Science Services has opened three new offices in Poland, Czech Republic and Romania as part of an initiative to expand its Global Clinical Development (GCD) services. The offices located in Prague, Warsaw, and Bucharest, respectively, will provide clinical trial monitoring services, study feasibility, and site selection, as well as support the regulatory aspects in these countries.
   
“The opening of the new offices addresses the request of many of our sponsors to conduct trials in Central and Eastern Europe in order to benefit from the vast pool of treatment-naïve patients, faster enrolment times, and the cost benefits these countries offer,” said Luc Braeken, vice president of Global Clinical Development. “Highly qualified and motivated investigators, low drop out rates of enrolled patients and the high quality of the clinical data are additional advantages of conducting trials in Central and Eastern Europe.”
    
The offices are staffed with teams experienced in conducting clinical trials in the pharmaceutical and CRO industry as well as in academia. The teams cover a wide range of therapeutic areas with special emphasis in CNS, infectious disease and cardiovascular disease. Also, SGS’ main office for GCD in Belgium will provide complementary services including project management, data management and statistics, regulatory affairs, and medical affairs.  

News from our sister sites